Supernus Pharmaceuticals
SUPN
#4182
Rank
HK$20.38 B
Marketcap
HK$355.60
Share price
1.29%
Change (1 day)
23.54%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Net assets

Net assets on the balance sheet as of September 2025 : HK$8.17 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has HK$8.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Supernus Pharmaceuticals - Net assets on balance sheet (from 2009 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$8.04 B11.72%
2023-12-31$HK$7.19 B3.94%
2022-12-31$HK$6.92 B8.84%
2021-12-31$HK$6.36 B10.17%
2020-12-31$HK$5.77 B24.52%
2019-12-31$HK$4.63 B30.72%
2018-12-31$HK$3.54 B69.76%
2017-12-31$HK$2.08 B40.54%
2016-12-31$HK$1.48 B117.99%
2015-12-31$HK$0.68 B116.08%
2014-12-31$HK$0.31 B21.65%
2013-12-31$HK$0.25 B-41.85%
2012-12-31$HK$0.44 B508.43%
2011-12-31$HK$73.34 M-121.26%
2010-12-31$-HK$0.35 Billion622.59%
2009-12-31$-HK$47.74 Million-8.45%
2008-12-31$-HK$52.14 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
United Therapeutics
UTHR
HK$51.30 B 527.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$185.66 B 2,172.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B 1,671.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$399.06 B 4,783.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$617.13 B 7,452.56%๐Ÿ‡บ๐Ÿ‡ธ USA